These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 22079477

  • 1. Cyclic nucleotide phosphodiesterases: critical modulators of endocrine, metabolic, and cardiovascular function and appealing therapeutic targets.
    Manganiello V.
    Curr Opin Pharmacol; 2011 Dec; 11(6):646-8. PubMed ID: 22079477
    [No Abstract] [Full Text] [Related]

  • 2. PDE inhibitors: a new approach to treat metabolic syndrome?
    Lugnier C.
    Curr Opin Pharmacol; 2011 Dec; 11(6):698-706. PubMed ID: 22018840
    [Abstract] [Full Text] [Related]

  • 3. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
    Kass DA.
    Circulation; 2007 Jul 17; 116(3):233-5. PubMed ID: 17638937
    [No Abstract] [Full Text] [Related]

  • 4. Phosphodiesterases and regulation of female reproductive function.
    Conti M.
    Curr Opin Pharmacol; 2011 Dec 17; 11(6):665-9. PubMed ID: 22019564
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents.
    Murray KJ, England PJ.
    Biochem Soc Trans; 1992 May 17; 20(2):460-4. PubMed ID: 1327922
    [No Abstract] [Full Text] [Related]

  • 9. Studies on the soluble phosphodiesterases of chicken gizzard smooth muscle.
    Birnbaum RJ, Head JF.
    Biochem J; 1983 Dec 01; 215(3):627-36. PubMed ID: 6318728
    [Abstract] [Full Text] [Related]

  • 10. Cyclic nucleotide phosphodiesterase activities of the embryonic chick ovary.
    Teng CT, Buchler B, Teng CS.
    Gen Comp Endocrinol; 1981 Aug 01; 44(4):409-17. PubMed ID: 6167486
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes--their potential utility in the therapy of asthma.
    Nicholson CD, Shahid M.
    Pulm Pharmacol; 1994 Feb 01; 7(1):1-17. PubMed ID: 8003849
    [No Abstract] [Full Text] [Related]

  • 13. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P, Prigent AF, Lagarde M, Nemoz G.
    Mol Pharmacol; 1993 Nov 01; 44(5):1027-35. PubMed ID: 8246905
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Measurements of cyclic AMP and cyclic GMP phosphodiesterase activity in isolated tubular segments.
    Jackson BA, Edwards RM, Dousa TP.
    Kidney Int; 1980 Oct 01; 18(4):512-8. PubMed ID: 6164816
    [No Abstract] [Full Text] [Related]

  • 17. Cyclic nucleotide phosphodiesterase assay technology.
    MacKenzie SJ, Hastings SF, Wells C.
    Curr Protoc Pharmacol; 2010 Jun 01; Chapter 3():Unit 3.12. PubMed ID: 22294369
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.